Carl L. Gordon, Ph.D., CFA

Carl L. Gordon, Ph.D., CFA, is a managing partner at OrbiMed Advisors LLC, an investment firm. Dr. Gordon has served on the board of directors of Compass Therapeutics Inc., a publicly held biopharmaceutical company, since September 2015, as well as several other privately held companies. He received a Bachelor of Arts in chemistry from Harvard College, a doctorate in molecular biology from the Massachusetts Institute of Technology and was a fellow at The Rockefeller University.